Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Virtus LifeSci Biotech Clinical Trials ETF BBC
$24.51
-$0.26 (-1.08%)
На 18:00, 12 мая 2023
Ключевые показатели
-
Marketcap
0.00000000
-
week52high
29.08
-
week52low
17.77
-
Revenue
-
P/E TTM
0
-
Beta
0.00000000
-
EPS
0.00000000
-
Last Dividend
0.44400000
-
Next Earnings Date
07 мая 2023 г. в 01:39
Описание компании
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
4 Best-Performing ETF Areas of Last Week
Zacks Investment Research
08 мая 2023 г. в 09:08
Wall Street offered a moderate-to-downbeat performance last week.
ALPS' Biotech ETF SBIO Week's Top Performer
ETF Trends
24 апр 2023 г. в 17:48
In a somewhat surprising turn, biotech and life sciences-focused ETFs were the driving themes in the last week's top-performing ETFs, with the ALPS Medical Breakthroughs ETF (SBIO) leading the way with a 10% return.
Best ETF Areas of Last Week
Zacks Investment Research
24 апр 2023 г. в 14:28
Wall Street offered a flat performance last week. Biotech, platinum and home building were some of the areas that won last week.
3 ETF Areas Likely to be in Tight Spots Post Banking Crisis
Zacks Investment Research
14 мар 2023 г. в 09:11
Wall Street has been witnessing the biggest banking meltdown since 2008. These ETF investing areas are at tight spots.
Can Health Care Stocks Outperform Again In 2023?
Seeking Alpha
11 янв 2023 г. в 18:09
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.